Antibiotic Now Available in Capsule Form

Published Online: Friday, June 28, 2013
Follow Pharmacy_Times:
This article is brought to you by Lupin Pharmaceuticals, Inc.
 
Suprax (cefixime) is now available in 400 mg capsules as well as 400 mg tablets and 100 mg/5 ml and 200 mg/5 ml suspensions. The capsule form of the cephalosporin antibiotic is designed to provide a dosage form preferred by most patients. In a survey of 1000 patents, more than half preferred capsules over tablets, and respondents associated capsules with safety and increased efficacy.
 
Suprax capsules can be taken once-daily, just like the 400 mg tablet form, and can be administered without food. However, neither the capsule nor the tablet form should be substituted for chewable tablets or suspension in treatment of otitis media in children. Suprax 400 mg capsules are available in a 10-pack and can be purchased using the $25 Suprax co-pay savings card. For details, go to www.supraxrx.com.
 
Suprax is indicated for treatment of otitis media caused by Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes; pharyngitis and tonsillitis caused by S pyogenes; acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae and H influenzae; and uncomplicated urinary tract infections caused by Escherichia coli and Proteus mirabilis.
 

Related Articles
Commonly cited estimates on how easily newly infected patients transmit HIV may be vastly overstated.
Pharmacists can serve as an important resource for patients traveling abroad.
Tablets that incorporate mobile health (mHealth) technology may help health care professionals screen pregnant patients for depression.
Patients who received ampicillin and ceftriaxone were less likely to have new onset renal failure.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$